secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPT Therapeutics, Inc. (—)
CIK:        0001673772
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0000950170-25-002193
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

RAPT Therapeutics appoints Lori Lyons-Williams as Board Chair; Rieflin resigns
------------------------------------------------------------------------------

- William Rieflin resigned from Board effective Jan 3, 2025; no disagreement with company.
- He continues as consultant; Board size reduced to six directors.
- Lori Lyons-Williams appointed Chair of the Board on Jan 5, 2025.
- Linda Kozick appointed to Audit Committee in connection with changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1673772/000095017025002193/0000950170-25-002193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1673772/000095017025002193/rapt-20250103.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-002193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer